UROTHELIAL CARCINOMA RECURRENT
Clinical trials for UROTHELIAL CARCINOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CARCINOMA RECURRENT trials appear
Sign up with your email to follow new studies for UROTHELIAL CARCINOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a pill wipe out bladder tumors before surgery?
Disease control CompletedThis study tested a drug called pemigatinib in 30 people with a type of bladder cancer that keeps coming back. Participants took the drug for 4-6 weeks before their scheduled surgery to remove the tumor. The goal was to see if the drug could completely eliminate the cancer before…
Matched conditions: UROTHELIAL CARCINOMA RECURRENT
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
New bladder cancer drug shows promise in early trial
Disease control CompletedThis early-stage study tested a new drug called UGN-301 (zalifrelimab) in 51 people with recurrent non-muscle invasive bladder cancer. The drug was given directly into the bladder to see if it is safe and to find the best dose. The goal is to control the cancer and prevent it fro…
Matched conditions: UROTHELIAL CARCINOMA RECURRENT
Phase: PHASE1 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC